Metropolis Healthcare gains 2% as Q1 core business revenue grows 12%
Saurabh Mukherjea of Marcellus Investment Managers has also been consistently adding the stock in his Little Champs Portfolio, which focuses on investing in quality midcap and small-cap companies for a long term.
Metropolis Healthcare Ltd - 542650 - Business Update For 1St Quarter Ended June 30, 2023
In accordance with the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information in terms of Regulation 8 of the SEBI (Prohibition of Insider Trading) Regulations, 2015, we would like to update on the key business parameters of the Company on a Consolidated basis for the quarter ended June 30, 2023 i.e. Q1FY24. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
This is to inform you that the Nomination and Remuneration Committee, via circular resolution dated July 12, 2023 have inter alia approved the allotment of 9,884 Equity shares of Rs. 2/- each at an exercise price of Rs. 2/- each aggregating to Rs. 19,768/- against the Restrictive Stock Units ("RSU") vested in and exercised by the employees of the Company under the MHL-Restrictive Stock Unit Plan, 2020. Further, the said shares shall rank pari passu in all respects with the existing Equity shares of the Company. Metropolis Healthcare Ltd - 542650 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We herewith enclose the Certificate issued by M/s. Link Intime India Private Limited, Registrar and Transfer Agent (RTA) of the Company confirming the compliance of Regulation 74(5) of Securities & Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2023. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) on Thursday, 13th July 2023 for a group call through Tele/ Video conferencing and the Host for the said meeting is UBS Securities. Discussions will be based on publicly available information. No unpublished price-sensitive information (UPSI) is intended to be discussed during the interactions. Kindly note that changes may happen due to exigencies on the part of the Participants/Host/Company. Metropolis Healthcare Ltd - 542650 - Closure of Trading Window
This is to inform you that pursuant to the Company''s Code of Fair Disclosure of Unpublished Price Sensitive Information framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in securities of the Company by the Designated Persons of the Company and/ or their immediate relatives will be closed with effect from July 01, 2023 and shall remain closed up to 48 (Forty-Eight) hours after the declaration of the Financial Results of the Company for the quarter ending June 30, 2023. The date of the Board Meeting for approval of Financial Results of the Company for the quarter ending June, 2023, shall be intimated in due course. Metropolis Healthcare Ltd - 542650 - Appointment of Company Secretary and Compliance Officer
This is to inform you that the Board of Directors of the Company at their Meeting held on Monday, June 19, 2023 have approved the appointment of Ms. Neha Shah as Interim Company Secretary & Key Managerial Personnel of the Company w.e.f. June 20,2023. Ms. Neha will continue to act as Interim Compliance officer of the Company approved by the Board in its Meeting held on December 09, 2022 (Ref No: MHL/Sec&Legal/2022-23/77) In terms of Regulation 30(5) of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, Key Managerial Personnel's ('KMP') of the Company have been authorized severally for the purpose of determining materiality of an event or information and making disclosure of the same to the Stock Exchange(s). Accordingly, Ms. Neha Shah, Interim Company Secretary & Compliance Officer of the Company has also been authorized under the aforesaid regulation. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be conducting In person meetings (Non-Deal Roadshow) for Investors/Analysts (Participants) on June 19, 2023 to June 23, 2023 at USA with Kotak Institutional Investor being the host for the said meetings. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dear Sir / Madam, We would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) as per the details below. Day & Date: Wednesday, June 14, 2023 to Friday, June 16, 2023. Type of Interaction: In-person Meeting. Host: Axis Capital. Further, Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. Kindly note that changes may happen due to exigencies on the part of Participants / Host / Company Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dear Sir / Madam, We would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) as per the details below. Day & Date: Wednesday, June 07, 2023. Type of Interaction: In-person Meeting. Host: Morgan Stanley India Investment Forum. Further, discussions will be based on publicly available information. Kindly note that changes may happen due to exigencies on the part of the Participants / Host / Company.